Morgan AS, Sanderson PE, Borch RF, Tew KD, Niktsu Y, Takayana T, VonHoff DD, Izbicka E, Mangold G, Paul C, Broberg U, Mannervik B, Henner DW and Kauvar LM
National Institutes of Health research shows that early diagnosis enables doctors to start antibiotic treatment, which results in mild symptom relief and major decreases in both medical complications and disease spread
Most providers recommend pausing tirzepatide if you have fever, nausea, vomiting, or difficulty maintaining adequate food and fluid intake
For individuals with severe immunodeficiency or functional/anatomical asplenia who received PPSV23 before age 65, a second PPSV23 dose is recommended at least 5 years after the first dose and at least 1 year after PCV15 administration, even if the individual is not yet 65 years old
Personalized Medicine: Advances in personalized medicine are paving the way for more tailored treatments
Dark yellow hints at mild dehydration, so grab that water bottle and stay refreshed